Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.

Sanjiv S. Shah; Tomas Rodriguez; Joseph P. McGowan

doi:10.1086/374935

Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.

Sanjiv S. Shah, Tomas Rodriguez, Joseph P. McGowan

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

We describe the first case of Miller Fisher syndrome (opthalmoplegia, ataxia, and areflexia) associated with lactic acidosis as an adverse effect of receipt of an antiretroviral regimen containing stavudine. We review this syndrome in the context of recent descriptions of neuromuscular toxicities attributed to nucleoside analogue reverse-transcriptase inhibitor-induced mitochondrial toxicity.

Original language	English (US)
Pages (from-to)	e131-133
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	36
Issue number	10
DOIs	https://doi.org/10.1086/374935
State	Published - May 15 2003
Externally published	Yes

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/374935

Cite this

Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy. / Shah, Sanjiv S.; Rodriguez, Tomas; McGowan, Joseph P.
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 36, No. 10, 15.05.2003, p. e131-133.

Research output: Contribution to journal › Article › peer-review

@article{4a8bf992ac3a4435a9b15619c040f0b7,

title = "Miller Fisher variant of Guillain-Barr{\'e} syndrome associated with lactic acidosis and stavudine therapy.",

abstract = "We describe the first case of Miller Fisher syndrome (opthalmoplegia, ataxia, and areflexia) associated with lactic acidosis as an adverse effect of receipt of an antiretroviral regimen containing stavudine. We review this syndrome in the context of recent descriptions of neuromuscular toxicities attributed to nucleoside analogue reverse-transcriptase inhibitor-induced mitochondrial toxicity.",

author = "Shah, {Sanjiv S.} and Tomas Rodriguez and McGowan, {Joseph P.}",

year = "2003",

month = may,

day = "15",

doi = "10.1086/374935",

language = "English (US)",

volume = "36",

pages = "e131--133",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.

AU - Shah, Sanjiv S.

AU - Rodriguez, Tomas

AU - McGowan, Joseph P.

PY - 2003/5/15

Y1 - 2003/5/15

N2 - We describe the first case of Miller Fisher syndrome (opthalmoplegia, ataxia, and areflexia) associated with lactic acidosis as an adverse effect of receipt of an antiretroviral regimen containing stavudine. We review this syndrome in the context of recent descriptions of neuromuscular toxicities attributed to nucleoside analogue reverse-transcriptase inhibitor-induced mitochondrial toxicity.

AB - We describe the first case of Miller Fisher syndrome (opthalmoplegia, ataxia, and areflexia) associated with lactic acidosis as an adverse effect of receipt of an antiretroviral regimen containing stavudine. We review this syndrome in the context of recent descriptions of neuromuscular toxicities attributed to nucleoside analogue reverse-transcriptase inhibitor-induced mitochondrial toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0346014799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346014799&partnerID=8YFLogxK

U2 - 10.1086/374935

DO - 10.1086/374935

M3 - Article

C2 - 12746793

AN - SCOPUS:0346014799

SN - 1058-4838

VL - 36

SP - e131-133

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 10

ER -

Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this